Test Research (TPE:3030) Cyclically Adjusted Revenue per Share: NT$26.81 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:3030 Test Research Inc TPE:3030
92 GF Score
Price NT$292.50
GF Value NT$189.90
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Test Research Cyclically Adjusted Revenue per Share?

Test Research TPE:3030 -1.35% 92 Cyclically Adjusted Revenue per Share is NT$26.81 as of Mar. 2026. GuruFocus rates TPE:3030 with a GF Score™ of 92/100 and a GF Value™ of NT$189.90 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Test Research's adjusted revenue per share for the three months ended in Mar. 2026 was NT$10.326. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$26.81 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Test Research's average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Test Research was 5.70% per year. The lowest was 2.70% per year. And the median was 4.20% per year.

As of today (2026-07-24), Test Research's current stock price is NT$292.50. Test Research's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$26.81. Test Research's Cyclically Adjusted PS Ratio of today is 10.91.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Test Research was 15.65. The lowest was 2.08. And the median was 2.76.


Test Research  (TPE:3030) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Test Research's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=292.50/26.81
=10.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Test Research was 15.65. The lowest was 2.08. And the median was 2.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Test Research Cyclically Adjusted Revenue per Share Related Terms


Test Research Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Test Research's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Test Research Cyclically Adjusted Revenue per Share Chart

Test Research Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.36 23.70 24.11 24.21 25.71

Test Research Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.69 25.16 25.30 25.71 26.81

TPE:3030 vs COHR, KEYS, GRMN: Cyclically Adjusted Revenue per Share Comparison

For the Scientific & Technical Instruments subindustry, Test Research's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Test Research Cyclically Adjusted PS Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Test Research's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Test Research's Cyclically Adjusted PS Ratio falls into.


TPE:3030
92GF Score
Test Research Inc TPE:3030
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Test Research Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Test Research's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=10.326/330.2130*330.2130
=10.326

Current CPI (Mar. 2026) = 330.2130.

Test Research Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.236 241.018 5.804
201609 3.055 241.428 4.178
201612 2.748 241.432 3.759
201703 3.178 243.801 4.304
201706 3.738 244.955 5.039
201709 4.686 246.819 6.269
201712 3.601 246.524 4.823
201803 4.497 249.554 5.950
201806 6.704 251.989 8.785
201809 5.278 252.439 6.904
201812 4.291 251.233 5.640
201903 4.120 254.202 5.352
201906 5.146 256.143 6.634
201909 4.429 256.759 5.696
201912 4.843 256.974 6.223
202003 4.914 258.115 6.287
202006 6.274 257.797 8.036
202009 5.765 260.280 7.314
202012 3.982 260.474 5.048
202103 5.698 264.877 7.103
202106 6.571 271.696 7.986
202109 5.858 274.310 7.052
202112 5.577 278.802 6.605
202203 8.119 287.504 9.325
202206 7.782 296.311 8.672
202209 6.513 296.808 7.246
202212 5.946 296.797 6.615
202303 4.931 301.836 5.395
202306 3.955 305.109 4.280
202309 4.343 307.789 4.659
202312 5.511 306.746 5.933
202403 6.388 312.332 6.754
202406 7.299 314.175 7.672
202409 6.868 315.301 7.193
202412 6.300 315.605 6.592
202503 8.205 319.799 8.472
202506 10.077 322.561 10.316
202509 8.739 324.800 8.885
202512 8.795 324.054 8.962
202603 10.326 330.213 10.326

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$26.81 mean?
Test Research (TPE:3030) has a Cyclically Adjusted Revenue per Share of NT$26.81 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Test Research and its competitors.
Is Test Research's Cyclically Adjusted Revenue per Share too high?
Test Research's current Cyclically Adjusted Revenue per Share is NT$26.81. Overall, Test Research has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Test Research's Cyclically Adjusted Revenue per Share compare to COHR and KEYS?
Test Research's Cyclically Adjusted Revenue per Share of NT$26.81 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Hardware company?
A good Cyclically Adjusted Revenue per Share depends on the Hardware industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Test Research and its competitors. Test Research's current Cyclically Adjusted Revenue per Share is NT$26.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Test Research stock overvalued right now?
Based on GuruFocus' analysis, Test Research (TPE:3030) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$189.90, compared to a current price of NT$292.50 — trading 54% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$26.81. Test Research's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Test Research (TPE:3030), the current Cyclically Adjusted Revenue per Share is NT$26.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Test Research (TPE:3030) Overvalued in 2026?

Based on GuruFocus' analysis, Test Research stock appears to be overvalued. The current stock price of NT$292.50 is trading 54% above its estimated GF Value™ of NT$189.90. GuruFocus considers Test Research to be Significantly Overvalued.

Key valuation signals for TPE:3030:

  • Cyclically Adjusted Revenue per Share: NT$26.81
  • GF Value™: NT$189.90 vs. price of NT$292.50 (54% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the TPE:3030 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Test Research Business Description

Address No. 45, Dexing W. Road, 7th Floor, Shilin District, Taipei, TWN, 11158
Test Research Inc designs testing equipment for industrial applications. The firm focuses on designing, assembling, manufacturing, selling, repairing, and maintaining automated inspection and testing equipment. The firm receives a majority of its revenue from Asia and the rest from America, Europe, and other regions.
92GF Score

Get the complete analysis for TPE:3030

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$292.50
Price
NT$189.90
GF Value